Influence of pH and phosphate concentration on the phosphate binding capacity of five contemporary binders. An in vitro study

Nephrology
Stefan P SchumacherAegida Neradova

Abstract

Hyperphosphataemia is associated with increased mortality and morbidity in end stage renal disease. Despite phosphate binder therapy, a large proportion of patients do not reach the treatment target. In five contemporary binders we explored the influence of pH and phosphate concentration on phosphate binding. This interaction could be of relevance in clinical practice. Phosphate binding was quantified in vitro in 25 mL of purified water containing phosphate concentrations of 10, 15 and 20 mM and baseline pH values of 3.0 or 6.0, with a binder over 6 h. Lanthanum carbonate, calcium acetate/magnesium carbonate, sevelamer carbonate, calcium carbonate and sucroferric oxyhydroxide, 67 mg of each, were used. The experiments were performed in duplicate. The primary outcome was the difference in the amount of bound phosphate for each binder after 6 h in solutions at two different pH values. Secondary outcomes were the influence of phosphate concentration on phosphate binding, next to binding patterns and phosphate binder saturation. In this specific in vitro setting, lanthanum carbonate, sevelamer carbonate, calcium carbonate and sucroferric oxyhydroxide bound more phosphate in the solution with baseline pH of 3.0. Differences however ...Continue Reading

References

Dec 1, 1989·Alimentary Pharmacology & Therapeutics·J FallingborgH H Rasmussen
Jan 1, 1989·The Journal of Clinical Investigation·M S SheikhJ S Fordtran
Feb 1, 1993·Pharmaceutical Research·T L RussellJ B Dressman
May 1, 1997·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·D P RosenbaumD I Goldberg
Apr 9, 2001·The Journal of Pharmacy and Pharmacology·B J RankinN B Roberts
Dec 17, 2004·Journal of the American Society of Nephrology : JASN·Holly KramerRonald Victor
May 15, 2007·Journal of Pharmaceutical Sciences·Valerie AutissierRichard A Henderson
May 18, 2007·Journal of Pharmaceutical Sciences·Edward A RossChristopher D Batich
Apr 21, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Richard A Sherman, Ojas Mehta
Apr 7, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Katrin UhligStanley Goldfarb
Feb 23, 2011·Seminars in Dialysis·John T DaugirdasUNKNOWN Frequent Hemodialysis Network Trial Group
Jan 22, 2013·Journal of Pharmaceutical Sciences·Yongsheng YangMansoor A Khan
Aug 8, 2014·International Journal of Pharmaceutics·Reem ElsiddigPeter McLoughlin
Apr 14, 2015·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Giuseppe CoppolinoMichele Buemi
Jun 27, 2015·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Rajiv SaranKevin C Abbott
Oct 29, 2015·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Richard A Sherman
Dec 5, 2015·PloS One·Saurav GhimireSyed Tabish R Zaidi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.